Kuros Biosciences AG
CSBTF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $18 | $17 | $14 | $14 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $27 | $15 | $9 | $6 |
| Inventory | $14 | $9 | $7 | $5 |
| Other Curr. Assets | $2 | $3 | $3 | $2 |
| Total Curr. Assets | $61 | $45 | $33 | $27 |
| Property Plant & Equip (Net) | $4 | $3 | $3 | $3 |
| Goodwill | $24 | $19 | $25 | $24 |
| Intangibles | $18 | $15 | $16 | $17 |
| Long-Term Investments | $0 | $0 | $0 | $17 |
| Tax Assets | $3 | $2 | $0 | $5 |
| Other NC Assets | $0 | $0 | $0 | -$16 |
| Total NC Assets | $49 | $40 | $44 | $49 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $110 | $85 | $77 | $76 |
| Liabilities | – | – | – | – |
| Payables | $7 | $7 | $3 | $1 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $19 | $13 | $9 | $11 |
| Total Curr. Liab. | $27 | $21 | $12 | $13 |
| LT Debt | $1 | $1 | $1 | $2 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $2 | $0 | $0 | $0 |
| Other NC Liab. | $4 | $3 | $4 | $3 |
| Total NC Liab. | $6 | $5 | $5 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $2 | $2 |
| Total Liabilities | $33 | $26 | $17 | $19 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $4 | $4 | $4 |
| Retained Earnings | -$22 | -$45 | -$43 | -$42 |
| AOCI | $0 | $0 | $0 | $22 |
| Other Equity | $96 | $100 | $99 | $73 |
| Total Equity | $77 | $59 | $60 | $57 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $110 | $85 | $77 | $76 |
| Net Debt | -$16 | -$16 | -$12 | -$12 |